During the past decade, Acibadem Atakent Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Acibadem Atakent Hospital" #1 sponsor was "Acibadem University" with 7 trials, followed by "Diskapi Teaching and Research Hospital" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored and "F2G Biotech GmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Acibadem Atakent Hospital" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Turkish Society of Anesthesiology and Reanimation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Acibadem Atakent Hospital" are "Blood Transfusion" (2 trials), "Anemia" (1 trials), "Blood Loss Anemia" (1 trials), "Blood Loss, Surgical" (1 trials) and "Coagulation Disorder" (1 trials). Many other conditions were trialed in "Acibadem Atakent Hospital" in a lesser frequency.

Most popular intervention types in "Acibadem Atakent Hospital" are "Drug" (5 trials), "Other" (4 trials), "Procedure" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood transfusion" (2 trials), "JNJ-73763989" (2 trials), "Placebo" (2 trials), "Tenofovir disoproxil" (2 trials) and "ATM-AVI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Acibadem Atakent Hospital" are 12 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Acibadem Atakent Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Acibadem Atakent Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Acibadem Atakent Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".